Clinical Trials on Seasonal Influenza Vaccine in Switzerland

Total 50 results

University of Alberta
University of Lausanne Hospitals

Completed

Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Lung Transplant Recipients

Influenza Vaccine | Influenza Virus

Switzerland, Canada
University of Lausanne Hospitals

Completed

Imiquimod and Influenza Vaccine for Immunocompromised Patients (IMIFLU)

Influenza Vaccine

Switzerland
Insel Gruppe AG, University Hospital Bern

Recruiting

Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy (IMCAR)

Vaccine Immunity in CAR-T Cell Therapy Recipients

Switzerland
University Hospital, Basel, Switzerland

Completed

Role of Interferon-λ and Vaccine Response

Allogeneic Stem Cell Transplantation | Vaccine Response Impaired

Switzerland
University of Zurich

Completed

SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19 (DER-CoV2-001)

Vaccine Reaction

Switzerland
University Hospital, Basel, Switzerland
University of Oslo; University of Oxford; Academisch Medisch Centrum - Universiteit...

Completed

Antibodies in Repeated Influenza Vaccination (ARIVA) Study (ARIVA)

Vaccine Response Impaired

Switzerland
Novartis
Novartis Vaccines

Completed

Safety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu Vaccine

Influenza Infection

Switzerland
University of Zurich
Schweizerischer Nationalfonds

Completed

Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting (TransFLUas)

Human Influenza

Switzerland
Ente Ospedaliero Cantonale, Bellinzona

Completed

This is a Study to Evaluate if Music Therapy Can Reduce Stress and Increase Satisfaction of Patients Undergoing Ambulatory Surgery

Stress | Personal Satisfaction

Switzerland
University Hospital, Basel, Switzerland

Completed

Ultrasound and Immunological Findings in Patients With Shoulder Injury Related to Vaccine Administration (SIRVA) (SIRVA)

Shoulder Injury Related to Vaccine Administration | Erosion, Localized

Switzerland
University Hospital, Geneva

Recruiting

Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines (Pertagen2x)

Pertussis | Vaccine-Preventable Diseases

Switzerland
Nestlé

Completed

Immune-modulatory Effect of Probiotic Strain on Grass Pollen Allergic Individuals

Seasonal Allergic Rhinitis

Switzerland
Crucell Holland BV

Completed

Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains

Influenza

Switzerland
Novartis Vaccines

Completed

Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines

Influenza

Switzerland
Crucell Holland BV

Completed

Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains

Influenza

Switzerland
Crucell Holland BV

Completed

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2008/2009 Influenza Virus Strains for the Northern Hemisphere

Influenza

Switzerland
Crucell Holland BV

Completed

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere

Influenza

Switzerland
Crucell Holland BV

Completed

Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Different Suppliers

Influenza

Switzerland
Crucell Holland BV

Completed

A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2009/2010 Influenza Virus Strains for the Northern Hemisphere

Influenza

Switzerland
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

Pandemic Influenza

Switzerland, Belgium, Germany
University Hospital, Basel, Switzerland
University of Basel; Swiss Federal Institute of Technology; University Children...

Completed

Prospective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, Switzerland

Influenza

Switzerland
Crucell Holland BV

Completed

Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14)

Influenza

Switzerland
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

Pandemic Influenza

Switzerland, Belgium, Germany
Sanofi Pasteur, a Sanofi Company

Completed

Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation

Influenza

Switzerland
Crucell Holland BV

Completed

Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers

Influenza

Switzerland
Felix Mueller
Swiss Society for Psycholytic Therapy (SÄPT)

Enrolling by invitation

The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training (TherPsySE)

Personal Experience of Substance-assisted Therapy Using Psilocybin, MDMA, and LSD

Switzerland
University of Lausanne Hospitals

Completed

Rapid Flu Tests in Travelers With Fever

Influenza

Switzerland
Sanofi Pasteur, a Sanofi Company

Completed

A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine

Influenza | Orthomyxoviridae Infections

Switzerland, United Kingdom
University Hospital Inselspital, Berne
Merck Sharp & Dohme LLC; Boehringer Ingelheim; Abbott; Solvay Pharmaceuticals

Completed

Influenza Vaccination in Immunocompromized Patients

Immunosuppression

Switzerland
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity Study of the Influenza Vaccine in Adults

Influenza | Orthomyxoviridae Infections

Belgium, Germany, Switzerland
Cytos Biotechnology AG

Completed

Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy

Hypersensitivity

Switzerland
Mabylon AG

Enrolling by invitation

Identification of Allergen-reactive Antibodies in the Blood of Pollen Allergic Patients

Pollen Allergy

Switzerland
University of Zurich
AlleCure

Completed

A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy

Rhinoconjunctivitis Due to Grass Pollen Allergy

Switzerland
Centre Hospitalier Universitaire Vaudois

Completed

Evaluation of High Speed Laser Doppler Imaging Technology (HSL-DI)

Hay Fever

Switzerland
University Hospital Inselspital, Berne
CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et...

Unknown

Artificial Intelligence (AI) in Cardiotocography (CTG) Interpretation

To Introduce Artificial Intelligence (AI) and Machine Learning in Cardiotocography (CTG) Interpretation to Improve Clinical Use

Switzerland
Calmy Alexandra

Recruiting

Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls (Shingr'HIV)

RZV Vaccine (Shingrix ®)

Switzerland, France
Centre Hospitalier Universitaire Vaudois
GlaxoSmithKline; University of Lausanne; University of Lausanne Hospitals; World... and other collaborators

Completed

A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland

Ebola Vaccines

Switzerland
Johannes Scherr

Recruiting

GRIP: Maximum Isometric Grip Strength Assessed With Three Different Hand-held Dynamometers

Grip

Switzerland
University of Zurich

Active, not recruiting

Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study (ILIT-FNA)

Hypersensitivity | Rhinitis, Allergic, Seasonal | Hay Fever | Rhinoconjunctivitis

Switzerland
University of Zurich

Completed

Physiological Study to Determine the Allergic Skin Activity After Different Skin Preparation

Birch Pollen Allergy

Switzerland
University of Zurich

Completed

Comparison of the Influence of Different Skin Conditions on the Allergic Skin Reactivity to Epicutanous Allergen Exposure

Birch Pollen Allergy

Switzerland
Oriol Manuel
University of Zurich; University Hospital, Geneva; University Hospital, Basel... and other collaborators

Completed

Reducing the Burden of Influenza After Solid-Organ Transplantation (STOP-FLU)

Influenza | Organ Transplantation

Switzerland, Spain
University Medical Center Groningen
University of Zurich

Completed

Long-term Outcomes After Hypothermic Oxygenated Machine Perfusion of Donor Livers Using Real-world Data (HOPE-REAL)

Liver Transplantation | Organ Preservation | Hypothermic Machine Perfusion

Switzerland, Netherlands
University of Zurich
University of Aarhus

Active, not recruiting

Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract

Allergic Rhinitis Due to Grass Pollen | Allergic Rhinitis | Rhinitis, Allergic, Seasonal | Allergic Asthma | Rhinitis; Allergic, With Asthma

Switzerland
University Hospital, Basel, Switzerland

Completed

Active Specific Intranodal Immunotherapy of Recombinant Vaccinia Virus in Locally Advanced to Metastatic Melanoma

Melanoma

Switzerland
Novartis Vaccines

Completed

Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine

Novel Influenza A (H1N1) | A New Flu Virus of Swine Origin

Chile, Colombia, Germany, Switzerland
Patricia Schlagenhauf
University Hospital, Geneva; Swiss Tropical & Public Health Institute; ETH Zurich and other collaborators

Not yet recruiting

Infection Tracking in Travellers. The Project Aims to Identify Profiles of Travel-associated Illness and to Follow up on Long-term Sequelae of Arboviral Infections and Malaria (ITIT)

Diarrhea | Malaria | Influenza | SARS-CoV Infection | Dengue | Chikungunya | Zika | Travel-Related Illness | MERS

Switzerland
University Hospital, Geneva
ModernaTX, Inc.; University of Geneva, Switzerland

Active, not recruiting

Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study (MIViral)

SARS-CoV-2 Infection | RSV Infection | Influenza Viral Infections | Virus Shedding | Mucosal Immunity

Switzerland
Anergis

Completed

Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment

Birch Pollen Allergy

Sweden, France, Lithuania, Denmark, Latvia, Poland, Switzerland
Hoffmann-La Roche

Completed

A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.

Influenza, Human

United States, Spain, Belgium, Poland, Germany, United Kingdom, Chile, Estonia, Hungary, Italy, France, South Africa, Mexico, Israel, Brazil, Guatemala, Czechia, Lithuania, Argentina, Bulgaria, Canada, Colombia, Latvia, Romania, Switzer... and more

Clinical Trials on Seasonal Influenza Vaccine in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations